Fullerene derivatives as inhibitors of the SARS-CoV-2 main protease

被引：6
|
作者：
Katagishi, Daiki [1 ]
Yasuda, Daisuke [1 ]
Takahashi, Kyoko [2 ]
Nakamura, Shigeo [2 ]
Mashino, Tadahiko [1 ]
Ohe, Tomoyuki [1 ]
机构：
[1] Keio Univ, Fac Pharm, Dept Pharmaceut Sci, 1-5-30 Shibakoen,Minato Ku, Tokyo, Japan
[2] Nippon Med Sch, Dept Chem, 1-7-1 Kyonan Cho,Musashino, Tokyo, Japan
来源：
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2023年 / 80卷
关键词：
Fullerene; COVID-19; SARS-CoV-2; Main protease; REVERSE TRANSCRIPTASE INHIBITION; C-60; POLYMERASE;
D O I：
10.1016/j.bmcl.2022.129121
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
COVID-19 is an ongoing worldwide pandemic. Even today, there is a need for the development of effective therapeutic agents. SARS-CoV-2 is known as the causative virus of COVID-19, and its main protease is one of the enzymes essential for its growth and is considered a drug discovery target. In this study, we evaluated the inhibitory activities of a variety of fullerene derivatives, including newly synthesized derivatives, against the main protease of SARS-CoV-2. As a result, the malonic acid-type fullerene derivatives showed the strongest inhibitory activity.
引用
收藏
页数：5
相关论文
共 50 条
  • [31] Potential Self-Peptide Inhibitors of the SARS-CoV-2 Main Protease
    Banerjee, Arkadeep
    Gosavi, Shachi
    JOURNAL OF PHYSICAL CHEMISTRY B, 2023, 127 (04): : 855 - 865
  • [32] Azapeptides with unique covalent warheads as SARS-CoV-2 main protease inhibitors
    Khatua, Kaustav
    Alugubelli, Yugendar R.
    Yang, Kai S.
    Vulupala, Veerabhadra R.
    Blankenship, Lauren R.
    Coleman, Demonta
    Atla, Sandeep
    Chaki, Sankar P.
    Geng, Zhi Zachary
    Xiao, Jing
    Chen, Peng-Hsun
    Cho, Chia-Chuan D.
    Sharma, Shivangi
    Vatansever, Erol C.
    Ma, Yuying
    Yu, Ge
    Neuman, Benjamin W.
    Xu, Shiqing
    Liu, Wenshe Ray
    ANTIVIRAL RESEARCH, 2024, 225
  • [33] Search of Novel Small Molecule Inhibitors for the Main Protease of SARS-CoV-2
    Zhang, Wenfa
    Lin, Sheng-Xiang
    VIRUSES-BASEL, 2023, 15 (02):
  • [34] Design of novel and highly selective SARS-CoV-2 main protease inhibitors
    Poli, Adi N. R.
    Tietjen, Ian
    Nandwana, Nitesh K.
    Cassel, Joel
    Messick, Troy E.
    Register, Emery T.
    Keeney, Frederick
    Rajaiah, Rajesh
    Verma, Atul K.
    Pandey, Kabita
    Acharya, Arpan
    Byrareddy, Siddappa N.
    Montaner, Luis J.
    Salvino, Joseph M.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2024, 68 (10)
  • [35] In Silico Identification of Potential Inhibitors of SARS-CoV-2 Main Protease (Mpro)
    Hernandez-Serda, Manuel Alejandro
    Vazquez-Valadez, Victor H.
    Aguirre-Vidal, Pablo
    Markarian, Nathan M.
    Medina-Franco, Jose L.
    Cardenas-Granados, Luis Alfonso
    Alarcon-Lopez, Aldo Yoshio
    Martinez-Soriano, Pablo A.
    Velazquez-Sanchez, Ana Maria
    Falfan-Valencia, Rodolfo E.
    Angeles, Enrique
    Abrahamyan, Levon
    PATHOGENS, 2024, 13 (10):
  • [36] Molecular Docking Unveils Prospective Inhibitors for the SARS-COV-2 Main Protease
    Ahmad, Fawad
    Ikram, Saima
    Ahmad, Jamshaid
    Rehman, Irshad Ur
    Khattak, Saeed Ullah
    Butt, Sadia
    Mushtaq, Maryam
    SAINS MALAYSIANA, 2021, 50 (05): : 1473 - 1484
  • [37] In silico assessment of diterpenes as potential inhibitors of SARS-COV-2 main protease
    Abdelrady, Yousef A.
    Ashraf, Naeem Mahmood
    Hamid, Arslan
    Thabet, Hayam S.
    Sayed, Asmaa M.
    Salem, Shimaa H.
    Hassanein, Emad H. M.
    Sayed, Ahmed M.
    FUTURE VIROLOGY, 2023, 18 (05) : 295 - 308
  • [38] Validation of baicalein and oridonin as nonspecific SARS-CoV-2 main protease inhibitors
    Yan, Haohao
    Zhang, Rui
    Yan, Gangan
    Liu, Xiaoping
    Li, Ni
    Chen, Yunyu
    PHYTOTHERAPY RESEARCH, 2024, 38 (03) : 1161 - 1164
  • [39] Challenges of short substrate analogues as SARS-CoV-2 main protease inhibitors
    Ullrich, Sven
    Sasi, Vishnu M.
    Mahawaththa, Mithun C.
    Ekanayake, Kasuni B.
    Morewood, Richard
    George, Josemon
    Shuttleworth, Laura
    Zhang, Xiaobai
    Whitefield, Cassidy
    Otting, Gottfried
    Jackson, Colin
    Nitsche, Christoph
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2021, 50
  • [40] Cysteine focused covalent inhibitors against the main protease of SARS-CoV-2
    Paul, Archi Sundar
    Islam, Rajib
    Parves, Md Rimon
    Al Mamun, Abdulla
    Shahriar, Imrul
    Hossain, Md Imran
    Hossain, Md Nayeem
    Ali, Md Ackas
    Halim, Mohammad A.
    JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2022, 40 (04): : 1639 - 1658
12345